Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1972 1
1973 1
1981 1
1983 3
1984 1
1985 3
1986 1
1987 2
1988 2
1991 1
1992 2
1993 2
1995 1
1996 1
1997 1
1998 1
2007 1
2013 1
2014 1
2016 1
2017 1
2018 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

29 results
Results by year
Filters applied: . Clear all
Page 1
Consensus on management of metastatic colorectal cancer in Central America and the Caribbean: San José, Costa Rica, August 2016.
López RI, Castro JL, Cedeño H, Cisneros D, Corrales L, González-Herrera I, Lima-Pérez M, Prestol R, Salinas R, Soriano-García JL, T Zavala A, Zetina LM, Zúñiga-Orlich CE. López RI, et al. ESMO Open. 2018 Mar 15;3(3):e000315. doi: 10.1136/esmoopen-2017-000315. eCollection 2018. ESMO Open. 2018. PMID: 29636987 Free PMC article. Review.
Chronic meningitis caused by Cladosporium trichoides.
Bennett JE, Bonner H, Jennings AE, Lopez RI. Bennett JE, et al. Among authors: lopez ri. Am J Clin Pathol. 1973 Mar;59(3):398-407. doi: 10.1093/ajcp/59.3.398. Am J Clin Pathol. 1973. PMID: 4734528 No abstract available.
Bevacizumab plus paclitaxel versus placebo plus paclitaxel as first-line therapy for HER2-negative metastatic breast cancer (MERiDiAN): A double-blind placebo-controlled randomised phase III trial with prospective biomarker evaluation.
Miles D, Cameron D, Bondarenko I, Manzyuk L, Alcedo JC, Lopez RI, Im SA, Canon JL, Shparyk Y, Yardley DA, Masuda N, Ro J, Denduluri N, Hubeaux S, Quah C, Bais C, O'Shaughnessy J. Miles D, et al. Among authors: lopez ri. Eur J Cancer. 2017 Jan;70:146-155. doi: 10.1016/j.ejca.2016.09.024. Epub 2016 Nov 4. Eur J Cancer. 2017. PMID: 27817944 Free article. Clinical Trial.
IgE in leprosy.
Lynch NR, Lopez RI. Lynch NR, et al. Among authors: lopez ri. Int J Lepr Other Mycobact Dis. 1983 Sep;51(3):416-7. Int J Lepr Other Mycobact Dis. 1983. PMID: 6685710 No abstract available.
2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial.
Smith I, Procter M, Gelber RD, Guillaume S, Feyereislova A, Dowsett M, Goldhirsch A, Untch M, Mariani G, Baselga J, Kaufmann M, Cameron D, Bell R, Bergh J, Coleman R, Wardley A, Harbeck N, Lopez RI, Mallmann P, Gelmon K, Wilcken N, Wist E, Sánchez Rovira P, Piccart-Gebhart MJ; HERA study team. Smith I, et al. Among authors: lopez ri. Lancet. 2007 Jan 6;369(9555):29-36. doi: 10.1016/S0140-6736(07)60028-2. Lancet. 2007. PMID: 17208639 Clinical Trial.
Trastuzumab retreatment after relapse on adjuvant trastuzumab therapy for human epidermal growth factor receptor 2-positive breast cancer: final results of the Retreatment after HErceptin Adjuvant trial.
Láng I, Bell R, Feng FY, Lopez RI, Jassem J, Semiglazov V, Al-Sakaff N, Heinzmann D, Chang J. Láng I, et al. Among authors: lopez ri. Clin Oncol (R Coll Radiol). 2014 Feb;26(2):81-9. doi: 10.1016/j.clon.2013.08.011. Epub 2013 Sep 17. Clin Oncol (R Coll Radiol). 2014. PMID: 24051172 Clinical Trial.
29 results